NCT00169611View on ClinicalTrials.gov

NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Neurofibromatosis Type 1
Interventions
DRUG

methylphenidate

Trial Locations (1)

69005

Laurence LION-FRANCOIS, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT00169611 - NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate | Biotech Hunter | Biotech Hunter